RxDoctor Payments DataLook up a doctor →

Gary Gelbfish, MD

Vascular Surgery · New York, NYNPI 1275508954

Payments from drug & device makers

$1,928,972in general payments, 2019–2025

Across 11 payments — averaging $175,361 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.9M
  • Bard Peripheral Vascular, Inc.$187
  • Boston Scientific$46
  • Takeda Pharmaceuticals U.S.A., Inc.$24
  • Medtronic$20
  • Argon Medical Devices, Inc.$17
  • plus $17 from 1 others

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,928,972 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York

Medicare billing

Part B allowed, 2024
$1,906,232
Medicare patients
520
Services billed
7,751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →